Emergency preparedness for biological and chemical incidents: A survey of anesthesiology residency programs in the United States

Anesthesia and Analgesia

Volumn 101, Issue 4, 2005, Pages 1135-1140

  Candiotti, Keith A ^a   Kamat, Aimee ^a   Barach, Paul ^a   Nhuch, Fani ^a   Lubarsky, David ^a   Birnbach, David J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN; BOTULINUM TOXIN A; CHEMICAL AGENT; SARIN;

ANESTHESIOLOGY; ANTHRAX; ARTICLE; BIOLOGICAL WARFARE; CHEMICAL WARFARE; DISASTER PLANNING; EDUCATION PROGRAM; FIRST AID; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL PERSONNEL; HUMAN; PRIORITY JOURNAL; RESIDENCY EDUCATION; RESPONSIBILITY; TRAINING; UNITED STATES;

EID: 25644437769     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000167642.11429.f5     Document Type: Article

References (17)

1. Chemical and biological terrorism: research and development to improve civilian medical response. National Research Council: Institute of Medicine, National Academy Press, 1999.
2. Macintyre AG, Christopher GW, Eitzen E Jr, et al. Weapons of mass destruction events with contaminated casualties. JAMA. 2000;283:242-9.
3. Zilinskas RA. Iraq's biological weapons: the past as future? JAMA. 1997;6:418-24.
4. Nozaki H, Hori S, Shinozawa Y, et al. Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 1995;21:1032-5.
5. National health and medical services response to incidents of chemical and biological terrorism. JAMA 1997;278:362-8.
6. American Hospital Association bioterrorism readiness plan: a template for health care facilities. Available at: http:// www.hospitalconnect.com/aha/ key_issues/disaster_readiness/ readiness/MaBioterrorismReadinessB1017.html. 2003.
7. Sigurdsson GH. Anesthesiologists should be familiar with the management of victims of terrorist attacks. Anesth Analg 2004; 98:1743-5.
8. Sampson JB. Anesthesiology leadership in medical preparedness for biological and chemical atrocities. ASA Newslett 2002; 66:15-6.
9. Treat KN, Williams JM, Furbee PM, et al. Hospital preparedness for weapons of mass destruction incidents: an initial assessment. Ann Emerg Med 2001;38:562-5.
10. Greenberg MI, Jurgens SM, Gracely EJ. Emergency department preparedness for the evaluation and treatment of victims of biological or chemical terrorist attack. J Emerg Med 2002;22: 273-8.
11. Agency for Healthcare Research and Quality. Understanding needs for health system preparedness and capacity for bioterrorist attacks. Available at: http://www.ahrq.gov/about/cpcr/ bioterrtxt.htm. 2001.
12. Barach P, Rivkind A, Israeli A, et al. Emergency preparedness and response in Israel during the Gulf War. Ann Emerg Med 1998;32:224-33.
13. Hendler I, Nahtomi O, Segal E, et al. The effect of full protective gear on intubation performance by hospital medical personnel. Mil Med 2000;165:272-4.
14. Barach P, Candiotti K. Current concepts in treatment of agents of mass destruction. In: Schwartz A, ed. Refresher courses in anesthesiology. Vol 32. Philadelphia, PA: Lippincott Williams & Wilkins, 2004:19-28.
15. Okumura T, Takasu N, Ishimatsu S, et al. Report of 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996;28: 128-35.
16. Vardi A, Berkenstadt H, Levin I, et al. Intraosseous vascular access in the treatment of chemical warfare casualties assessed by advanced simulation: proposed alteration of treatment protocol. Anesth Analg 2004;98:1753-8.
17. Hall M. Intelligence chiefs: terrorists intent on U.S. attack. USA Today 2005;Thursday, February 17:5A.